Found: 36
Select item for more details and to access through your institution.
Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.
- Published in:
- Journal of Surgical Oncology, 1989, v. 42, n. 3, p. 201, doi. 10.1002/jso.2930420315
- By:
- Publication type:
- Article
Prognosis of skin melanoma with regional node metastases (stage II).
- Published in:
- Journal of Surgical Oncology, 1984, v. 25, n. 4, p. 240, doi. 10.1002/jso.2930250404
- By:
- Publication type:
- Article
Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical Structures.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 6, p. 587, doi. 10.1001/jamadermatol.2023.0620
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2000, v. 7, n. 6, p. 469, doi. 10.1007/s10434-000-0469-z
- By:
- Publication type:
- Article
Number of Excised Lymph Nodes as a Quality Assurance Measure for Lymphadenectomy in Melanoma.
- Published in:
- JAMA Surgery, 2014, v. 149, n. 7, p. 700, doi. 10.1001/jamasurg.2013.5676
- By:
- Publication type:
- Article
Lymph-Node Ratio in Patients with Cutaneous Melanoma: A Multi-Institution Prognostic Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 7, p. 2127, doi. 10.1245/s10434-014-4132-5
- By:
- Publication type:
- Article
Single-Institution Series of Early-Stage Merkel Cell Carcinoma: Long-Term Outcomes in 95 Patients Managed with Surgery Alone.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2009, v. 16, n. 11, p. 2985, doi. 10.1245/s10434-009-0615-1
- By:
- Publication type:
- Article
Association of promoter polymorphism −765 G> C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts.
- Published in:
- Experimental Dermatology, 2014, v. 23, n. 10, p. 766, doi. 10.1111/exd.12522
- By:
- Publication type:
- Article
CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
- Published in:
- Experimental Dermatology, 2013, v. 22, n. 6, p. 411, doi. 10.1111/exd.12168
- By:
- Publication type:
- Article
High Levels of Exosomes Expressing CD63 and Caveolin- 1 in Plasma of Melanoma Patients.
- Published in:
- PLoS ONE, 2009, v. 4, n. 4, p. 1, doi. 10.1371/journal.pone.0005219
- By:
- Publication type:
- Article
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 999, doi. 10.1007/s00262-015-1704-6
- By:
- Publication type:
- Article
Armed antibodies for cancer treatment: a promising tool in a changing era.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 113, doi. 10.1007/s00262-014-1621-0
- By:
- Publication type:
- Article
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1223, doi. 10.1007/s00262-013-1428-4
- By:
- Publication type:
- Article
Effects of cyclophosphamide and IL-2 on regulatory CD4 T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 897, doi. 10.1007/s00262-013-1397-7
- By:
- Publication type:
- Article
Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1159, doi. 10.1007/s00262-008-0610-6
- By:
- Publication type:
- Article
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.
- Published in:
- Stem Cells, 2016, v. 34, n. 10, p. 2449, doi. 10.1002/stem.2413
- By:
- Publication type:
- Article
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan.
- Published in:
- 1994
- By:
- Publication type:
- journal article
What do we know about cutaneous melanoma of childhood?
- Published in:
- Contemporary Pediatrics, 2006, v. 23, n. 9, p. 42
- By:
- Publication type:
- Article
Retroperitoneal soft tissue sarcomas.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 11, p. 2448
- By:
- Publication type:
- Article
DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2002, v. 96, n. 5, p. 301, doi. 10.1002/cncr.10748
- By:
- Publication type:
- Article
Association Between Baseline Disease Characteristics and Relapse-Free Survival (RFS) in Patients (pts) with BRAF V600--Mutant Resected Stage III Melanoma Treated with Adjuvant Dabrafenib (D) + Trametinib (T) or Placebo (PBO).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 500
- By:
- Publication type:
- Article
Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 11, p. 2439, doi. 10.1002/ijc.22598
- By:
- Publication type:
- Article
Enrichment of CD56<sup>dim</sup>KIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients.
- Published in:
- Nature Communications, 2014, v. 5, n. 12, p. 5639, doi. 10.1038/ncomms6639
- By:
- Publication type:
- Article
Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 7, p. 1893, doi. 10.1038/jid.2014.29
- By:
- Publication type:
- Article
Response to Griewank and Bastian.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Heterogeneous Phenotype of Human Melanoma Cells with In Vitro and In Vivo Features of Tumor-Initiating Cells.
- Published in:
- Journal of Investigative Dermatology, 2010, v. 130, n. 7, p. 1877, doi. 10.1038/jid.2010.69
- By:
- Publication type:
- Article
Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT.
- Published in:
- Journal of Investigative Dermatology, 2009, v. 129, n. 7, p. 1759, doi. 10.1038/jid.2008.422
- By:
- Publication type:
- Article
CD133 POSTIVE CELLULAR POPULATION IN HUMAN MELANOMA.
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A32, doi. 10.1096/fasebj.21.5.a32-a
- By:
- Publication type:
- Article
pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 1, p. 207, doi. 10.1002/ijc.25009
- By:
- Publication type:
- Article
Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta‐analysis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 859, doi. 10.1111/jdv.18665
- By:
- Publication type:
- Article
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma.
- Published in:
- Journal of Surgical Oncology, 2013, v. 107, n. 2, p. 173, doi. 10.1002/jso.23168
- By:
- Publication type:
- Article
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1079, doi. 10.1002/onco.13926
- By:
- Publication type:
- Article
microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.
- Published in:
- Genes, 2016, v. 7, n. 12, p. 124, doi. 10.3390/genes7120124
- By:
- Publication type:
- Article
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02529-5
- By:
- Publication type:
- Article